obesity-995x60.png
FEATURED ARTICLES
The Five Economic Risks Pharma Can't Treat As Background Noise
U.S. pricing reforms are already delaying drug launches abroad. See five economic risks facing pharma and why leaders across functions must plan together.
-
Novel Science, Familiar Regulatory Pathways: Inside Tonix's Clinical Development Strategy
Tonix CEO Seth Lederman, MD, explains how the company pairs novel science with proven regulatory paths across fibromyalgia, depression, and Lyme disease.
-
Why Do Clinical Trials Cost So Much? Looking Beyond The Obvious
The true cost of research goes beyond budgets to design, data, and execution inefficiencies. Streamlining processes and early decisions reduces delays, controls costs, and improves study quality.
-
CRF Validation Best Practices: Building Reliable Clinical Trial Databases
CRF validation improves data quality and efficiency. Early planning, clear edit checks, and balance reduce rework, ease site burden, and enable more reliable, streamlined study execution.